CVS Health Corporation $CVS Shares Purchased by Farther Finance Advisors LLC

Key Points

• Farther Finance Advisors increased its CVS Health stake by 30.6% in the third quarter, purchasing 12,718 additional shares and bringing its holdings to 54,244 shares valued at approximately $4.65 million. Institutional investors and hedge funds own 80.66% of CVS shares.
• Analysts remain broadly positive, with 20 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $107.24 versus the reported share price of $86.15.
• CVS reported stronger-than-expected quarterly results, including $2.58 in EPS and $106.1 billion in revenue, while maintaining a quarterly dividend of $0.665, equivalent to a 3.1% annualized yield. However, weaker Aetna Medicare Advantage star-rating projections and ongoing 340B pricing pressure pose risks to margins and earnings.

Farther Finance Advisors LLC boosted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 30.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 54,244 shares of the pharmacy operator's stock after buying an additional 12,718 shares during the period. Farther Finance Advisors LLC's holdings in CVS Health were worth $4,648,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Kilter Group LLC acquired a new stake in shares of CVS Health in the second quarter worth $27,000. Sankala Group LLC acquired a new position in CVS Health during the 4th quarter valued at $28,000. Global Trust Asset Management LLC raised its stake in CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 300 shares during the last quarter. J.Safra Asset Management Corp bought a new stake in CVS Health in the 2nd quarter valued at $30,000. Finally, Beaird Harris Wealth Management LLC boosted its holdings in CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock valued at $30,000 after purchasing an additional 195 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Truist Financial raised their price target on shares of CVS Health from $108.00 to $118.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Bank of America boosted their price objective on shares of CVS Health from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Monday, June 22nd. BMO Capital Markets set a $112.00 price objective on shares of CVS Health in a research report on Wednesday, September 9th. Argus increased their target price on shares of CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a research note on Wednesday, August 19th. Finally, Sanford C. Bernstein reissued an "outperform" rating and set a $112.00 target price on shares of CVS Health in a research report on Wednesday, September 9th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $107.24.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS said more than 69% of Aetna’s Medicare Advantage members are enrolled in plans rated four stars or higher for 2027. The company highlighted solid clinical quality, preventive care and member-experience performance. Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
• Positive Sentiment: CVS extended pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032, supporting supply continuity for its retail pharmacies and other dispensing operations. CVS Health Extends Drug Distribution Deals
• Positive Sentiment: Analysts continue to point to potential upside from recovering Aetna margins, improving pharmacy trends, growth in Health Services and CVS’s valuation discount versus peers. The company also opened a compact, pharmacy-focused location in the Boston area, supporting its retail strategy. CVS Trades at a Discount to Industry
• Neutral Sentiment: Options traders reportedly purchased a large volume of CVS call options, signaling speculative bullish interest but not guaranteeing sustained buying in the shares. Traders Buy CVS Call Options
• Negative Sentiment: TD Cowen said Aetna’s 2027 results were weaker than expected, with the portion of Medicare Advantage members in plans rated at least 4.5 stars projected to fall to about 35% from 63%. The decline could reduce quality-related bonus payments and put pressure on Aetna’s earnings and margins. CVS Star Ratings Weaker Than Expected
• Negative Sentiment: The ratings setback has made CVS an underperformer among managed-care stocks, while competitors with stronger Medicare Advantage scores received more favorable investor reactions. Persistent 340B pricing pressure remains an additional risk to the recovery story.

CVS Health Price Performance

CVS Health stock opened at $86.15 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The company has a market capitalization of $110.18 billion, a PE ratio of 22.79, a price-to-earnings-growth ratio of 0.80 and a beta of 0.60. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The business has a 50 day simple moving average of $92.73 and a 200 day simple moving average of $92.37.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same quarter in the previous year, the firm earned $1.81 EPS. CVS Health's quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, sell-side analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be issued a $0.6650 dividend. The ex-dividend date of this dividend is Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.1%. CVS Health's dividend payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company's major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.